Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
69.82 USD | +0.13% | -2.59% | -5.12% |
May. 17 | Nuvalent Insider Sold Shares Worth $345,450, According to a Recent SEC Filing | MT |
May. 16 | Nuvalent Gets FDA Breakthrough Therapy Designation for Lung-Cancer Treatment | DJ |
Business Summary
Number of employees: 106
Managers
Managers | Title | Age | Since |
---|---|---|---|
James Porter
CEO | Chief Executive Officer | 48 | 16-12-31 |
Alexandra Balcom
DFI | Director of Finance/CFO | 40 | 20-12-31 |
Jeffrey Lee
CTO | Chief Tech/Sci/R&D Officer | - | 22-08-31 |
Philip Engel
CTO | Chief Tech/Sci/R&D Officer | - | 22-12-31 |
Benjamin Lane
COO | Chief Operating Officer | - | 20-09-30 |
Viola Zhu
CTO | Chief Tech/Sci/R&D Officer | - | - |
Ruth Adams
CTO | Chief Tech/Sci/R&D Officer | - | 20-10-31 |
Chief Tech/Sci/R&D Officer | 56 | 21-02-28 | |
- | - | ||
Jessie Lin
PRN | Corporate Officer/Principal | - | 21-08-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 53 | 21-06-30 | |
Anna Protopapas
CHM | Chairman | 59 | 22-03-29 |
Andrew Hack
BRD | Director/Board Member | 50 | 21-05-10 |
Cameron Wheeler
BRD | Director/Board Member | 45 | 17-01-31 |
Michael Meyers
BRD | Director/Board Member | 74 | 22-10-03 |
D. Gilliland
BRD | Director/Board Member | 69 | 20-12-31 |
James Porter
CEO | Chief Executive Officer | 48 | 16-12-31 |
Joseph Pearlberg
BRD | Director/Board Member | 60 | 20-12-31 |
Emily Conley
BRD | Director/Board Member | 42 | 22-02-01 |
Matthew Shair
FOU | Founder | 55 | 16-12-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 5,435,254 | 0 | 0 | 84.45 % |
Stock B | 1 | 59,120,876 | 54,517,768 ( 92.21 %) | 0 |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.12% | 4.51B | |
+64.23% | 62.59B | |
-2.31% | 41.18B | |
+45.15% | 40.29B | |
-8.29% | 27.9B | |
+11.97% | 26.21B | |
-21.16% | 19.09B | |
+7.54% | 13.08B | |
+27.17% | 12.05B | |
+25.72% | 12.26B |
- Stock Market
- Equities
- NUVL Stock
- Company Nuvalent, Inc.